Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul

Before his first week on the job was over, FDA Acting Commissioner Josh Sharfstein made decisive moves on two fronts, quickly stepping up regulation and taking steps toward an overhaul of the agency's internal culture